Wuhan EasyDiagnosis Biomedicine Co., Ltd (SHE: 002932), a Chinese biomedicine company, has announced a strategic partnership with Ailex Technology Group Co., Ltd. The collaboration aims to combine the companies’ respective strengths in technology, product development, market reach, and management expertise to make inroads into the global glycated hemoglobin testing market. Financial specifics of the agreement have not been disclosed.- Flcube.com
Recent news:
-
Three Senior Executives of Henan Topfond Pharmaceutical Under Investigation -
Leman Biotech Enters Zhongshan Life Science Park to Accelerate CAR-T Innovation -
BRL Medicine Inc. Secures Nearly $30 Million in B+ Round Financing to Advance Pipeline -
Chinese Biopharma Bio-Bank Corp. Aims for HKEX IPO, Focused on PDGF Therapies -
HutchMed Anticipates Milestone Payment as Takeda Launches Fruzaqla in Japan for CRC
